Procter & Gamble: Barclays Maintains Equal-Weight, PT Down to $153

Procter & Gamble: Barclays Maintains Equal-Weight, PT Down to $153

Barclays has downgraded Procter & Gamble (NYSE:PG) to an "Equal Weight" rating from "Overweight," while lowering its price target to $153 from $164. The brokerage cited several factors for the downgrade, including rising competition and limited growth prospects. However, Barclays maintained a "Buy" rating for the company, suggesting that while the stock may not be as attractive as before, it still offers a good investment opportunity.

The downgrade comes amidst a period of significant changes in Procter & Gamble's portfolio. The company recently reported its quarterly earnings, beating analysts' expectations with earnings per share (EPS) of $1.48, up from $1.40 a year ago. The company also increased its dividend payout ratio to 64.82%, indicating strong financial health.

Barclays' downgrade follows a recent trend of analysts adjusting their price targets for Procter & Gamble. Evercore ISI, for instance, reissued an "In-line" rating and set a $170.00 price objective, while BNP Paribas Exane cut their price target to $172.00. Despite these changes, Procter & Gamble remains one of the most highly-rated stocks among analysts, with an average rating of "Moderate Buy" and an average price target of $173.68.

The company's strong fundamentals and consistent dividend payouts make it an attractive investment for long-term investors. However, the recent downgrade by Barclays suggests that investors should closely monitor the company's performance and adjust their expectations accordingly.